Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double bronchodilator for pneumoconiosis with ventilatory dysfunction
ChiCTR2200057201Phase 4Not yet recruiting
- Sponsor
- 920th Hospital of Joint Logistics Support Force
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Anoro Ellipta in pneumoconiosis (2 arms), sponsored by 920th Hospital of Joint Logistics Support Force. Primary endpoint: forced expiratory volume in 1 second. Planned start Feb 2022; status: not yet recruiting.
02
Drugs
Anoro Ellipta
03
Conditions
pneumoconiosis
Beyond the preview
Go deeper on ChiCTR2200057201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200057201.